J. Lloyd Breedlove, President and CEO
J. Lloyd Breedlove
was appointed President and Chief Executive Officer of Anpath Group, Inc. and EnviroSystems and Chairman of Anpath Group, Inc.'s and EnviroSystems’ Board of Directors on January 10, 2006. Mr. Breedlove was previously a member of the Board of Directors of EnviroSystems. From June 2003 to January 2006, he was President and Chief Executive Officer of Imalux Corporation a corporation in the medical imaging equipment industry. Prior thereto, from December 2000 to May 2003 he was the President and Chief Executive Officer of KIVALO a healthcare technology company with emphasis on disease management. From 1991 to 1999, Mr. Breedlove served as the Executive Vice President and Group President at STERIS Corporation, a developer and manufacturer of infection and contamination control products. From 1989 to 1991, he was the President and Chief Executive Officer of CRI, a developer of a vascular surgery product and prior thereto he was the Director of Sales and held other sales and management positions at Mallinckrodt, Inc. a diverse company focusing on supplying products to the healthcare industry. Mr. Breedlove has a wide range of experience working with companies in various stages of development from start-ups to companies with global operations. During Mr. Breedlove’s tenure at STERIS, annual sales increased from $13 million to greater than $820 million. He has served on numerous advisory and corporate boards, with an emphasis on establishing healthcare businesses. Mr. Breedlove received an MBA from
Western
Carolina
University.
Serving in
Viet Nam,
he was awarded the Bronze Star, Bronze Star with Oak Leaf Cluster, Vietnamese Cross of Gallantry, Air Medal and Purple Heart.
Steve Hoelscher, Chief Financial Officer
Mr. Hoelscher was appointed Anpath Group, Inc.’s and EnviroSystems’ Chief Financial Officer, Secretary and a member of each of Anpath Group, Inc.’s and EnviroSystems’ Board of Directors on January 10, 2006. Mr. Hoelscher is a Certified Public Accountant and has 24 years of accounting and auditing experience. Mr. Hoelscher has been the CFO for Mastodon Ventures, Inc., a financial consulting business in Austin, Texas, from 2000 to the present. Mr. Hoelscher is also the Chief Financial Officer of the EnXnet, Inc, a
Tulsa
,
Oklahoma
based publicly traded technology company since
May 21, 2004
and has been providing accounting consulting services to EnXnet since January 2001. Mr. Hoelscher will continue to provide limited consultation to Mastodon and will continue to consult with EnXnet but will devote such time as necessary to the performance of his duties to us. Mr. Hoelscher was the Controller for Aperian, Inc. an Austin, Texas based publicly traded company from 1997 to 2000. Prior to joining Aperian, he was the controller for Protos Software Company in
Georgetown
,
Texas
from 1996 to 1997. Mr. Hoelscher was Audit Manager with Brown, Graham and Company, P.C. from 1989 to 1996. Mr. Hoelscher received a Bachelor of Business Administration from
West
Texas
A&M
University
(formerly
West
Texas
State
University)
in Canyon,
Texas
in 1981.
Paul Malchesky, D. Eng., Chief Science Officer
Paul S. Malchesky, D. Eng. has joined EnviroSystems and assumed the role of Chief Science Officer. Dr. Malchesky is a former Vice President of Operations and Discovery and Development for NanoScale Materials, Inc. in Manhattan, KS. Previously, he served as Vice President of Investigational Research at STERIS Corporation,
in Mentor,
OH, and St
aff Member at the Cleveland Clinic Foundation in Artificial Organs in Cleveland, OH. As an academician, Dr. Malchesky is Associate Professor of Surgery, Baylor College of Medicine,
Houston, Texas,
and Adjunct Staff in Biomedical Engineering, Cleveland Clinic Foundation, and Adjunct Professor in Chemical Engineering at Kansas State University. He is also President of the
International
Center
for Artificial Organs and Transplantation (ICAOT). Dr. Malchesky is also the Editor-in-Chief of Artificial Organs and Managing Editor of Therapeutic Apheresis and Dialysis. He holds a Doctorate in Engineering from Cleveland State University, M.S. degrees in Chemistry from
Case
Western Reserve
University
and in Chemical Engineering from
Cleveland
State
University
and a B.S. Degree in Chemistry from St. Francis College (PA).
Jeff Savino, Vice President of Sales and Marketing
Jeff Savino joins EnviroSystems as the Vice President of Marketing & Sales. Mr. Savino has nearly thirty years of proven experience in medical marketing and sales, spanning from small to large corporations. His background includes new product introductions, operations experience, and international commerce and business. Most recently he built and managed a national distribution network at Boehringer Labs. Previously, Mr. Savino held a number of responsible positions in his ten years of service with STERIS Corporation, including Vice President, International Health Care, Latin American Operations, and Country Manager for Australia, New Zealand, and Japan. His marketing and sales career began with Baxter. Mr. Savino holds a B.S. Degree in Biology from City University of New York.
Board of Directors
J. Lloyd Breedlove
, Chairman Board of Directors
(See Previous Information)
Steve Hoelscher, Director
(See previous Information)
Charles Cottrell, Director
Charles Cottrell was appointed as a member of Anpath Group, Inc.’s and EnviroSystems’ Board of Directors on January 10, 2006. Since 2001, Mr. Cottrell has served as a principal of Mountain Green LLC, a manufacturer and distributor of natural cleaning products, located in Scottsdale, Arizona. Prior thereto, from 1979 to 1999, he served as the Chairman and Chief Executive Officer of Cottrell Limited, an Englewood, Colorado based company providing infection control products and services to the national healthcare market. Mr. Cottrell has over 30 years experience in bringing new products to market and developing brands. Mr. Cottrell received a Bachelor of Science from the University of Pittsburgh, and attended the Wharton School of Business’ Entrepreneurial Studies and Growth Programs and the Harvard University Business School's Business Owners/President’s Program.
Jeffrey Connally, Director
Jeffrey Connally was appointed as a member of Anpath Group, Inc.’s and EnviroSystems’ Board of Directors on January 10, 2006. Mr. Connally also serves a director of CM IT Solutions, Inc. Mr. Connally is a partner in Gener8biz, Inc., a sales and marketing consulting firm which he founded in May of 2003. Mr. Connally leads strategic engagements for Gener8biz’ high-tech, healthcare and financial services clientele. Prior thereto, in 1998 Mr. Connally was a founder of UpLink Corporation where he provided sales and marketing leadership and created the marketing, business development, sales, installation and support infrastructure for UpLink’s wireless/GPS-based technology. Mr. Connally has also held executive positions with several startup technology companies where he was responsible for establishing the sales process and channel strategy. Mr. Connally received a Bachelors in Business Administration from
St.
Michaels
College
in 1969 and an MBA from the
University
of
Texas
in 1993.
Stephen A. Schneider, Director
Mr. Schneider currently serves as Chairman, President and CEO of AmbroZea, Inc., a company he co-founded in January 2006. AmbroZea is applying biotechnology to produce high-value ethanol co-products that create a significantly more reliable and more profitable business model for ethanol companies. He also serves as a member of Sand Hill Angels, Inc., in Silicon Valley, CA. In January 2006, prior to AmbroZea, Mr. Schneider was appointed to the Board of Directors of the Anpath Group, Inc. and its subsidiary EnviroSystems, Inc. (ESI). He had previously assumed the role of Interim President and Chief Executive Officer of ESI in November 2004, and in January 2006 he took the company public with an $8.5M PIPE investment. Mr. Schneider also has 20 years experience in the pharmaceutical, medical device and medical service industries where he developed a number of early stage companies. From 2001 through 2003, he served as President and COO of Alexza Pharmaceuticals, Inc. (Alexza). Alexza is a specialty pharmaceutical company developing ethical drug products delivered by inhalation using proprietary nano/micro-particle vaporization technology. Alexza was formed in December 2001 by a merger of equals between Alexza, Inc., founded by Alejandro Zaffaroni, Ph.D., and Molecular Delivery Corporation (MDC). Mr. Schneider had founded MDC and served as its President and Chief Executive Officer from 1997 to 2001, during which time the company developed the fundamental inhalation technology now in use at Alexza. From 1985 to 1989, he served as Director of Corporate Development at Corus Medical Corporation, storing autologous blood for patients needing blood transfusions. Mr. Schneider received his Bachelor of Arts from Earlham College, his Master of Arts from the University of Houston, and his JD from Golden Gate University of Law. He has also attended the Stanford University Graduate School of Business' Leadership Academy, Executive Program for Growing Companies and Finance and Accounting for Non-Finance Executive programs.
|
|
|
